|
1
|
Van Dijk SM, Hallensleben NDL, van
Santvoort HC, Fockens P, van Goor H, Bruno MJ and Besselink MG:
Dutch Pancreatitis Study Group. Acute pancreatitis: Recent advances
through randomised trials. Gut. 66:2024–2032. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Vege SS, DiMagno MJ, Forsmark CE, Martel M
and Barkun AN: Initial medical treatment of acute pancreatitis:
American gastroenterological association institute technical
review. Gastroenterology. 154:1103–1139. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mole DJ, Webster SP, Uings I, Zheng X,
Binnie M, Wilson K, Hutchinson JP, Mirguet O, Walker A, Beaufils B,
et al: Kynurenine-3-monooxygenase inhibition prevents multiple
organ failure in rodent models of acute pancreatitis. Nat Med.
22:202–209. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Maheshwari R and Subramanian RM: Severe
acute pancreatitis and necrotizing pancreatitis. Crit Care Clin.
32:279–290. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nesvaderani M, Eslick GD and Cox MR: Acute
pancreatitis: Update on management. Med J Aust. 202:420–423.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shah AP, Mourad MM and Bramhall SR: Acute
pancreatitis: Current perspectives on diagnosis and management. J
Inflamm Res. 11:77–85. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shamoon M, Deng Y, Chen YQ, Bhatia M and
Sun J: Therapeutic implications of innate immune system in acute
pancreatitis. Expert Opin Ther Targets. 20:73–87. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang B, Wu G, Zhou Z, Dai Z, Sun Y, Ji Y,
Li W, Wang W, Liu C, Han F and Wu Z: Glutamine and intestinal
barrier function. Amino Acids. 47:2143–2154. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cruzat V, Macedo Rogero M, Noel Keane K,
Curi R and Newsholme P: Glutamine: Metabolism and immune function,
supplementation and clinical translation. Nutrients.
10(1564)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Alhan E, Usta A, Türkyılmaz S, Kural BV
and Erçin C: Effects of glutamine alone on the acute necrotizing
pancreatitis in rats. J Surg Res. 193:161–167. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pan LL, Li J, Shamoon M, Bhatia M and Sun
J: Recent advances on nutrition in treatment of acute pancreatitis.
Front Immunol. 8(762)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yong L, Lu QP, Liu SH and Fan H: Efficacy
of glutamine-enriched nutrition support for patients with severe
acute pancreatitis: A meta-Analysis. JPEN J Parenter Enteral Nutr.
40:83–94. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu B, Huang W, Xiao X, Xu Y, Ma S and Xia
Z: Neuroprotective effect of ulinastatin on spinal cord
ischemia-reperfusion injury in rabbits. Oxid Med Cell Longev.
2015(624819)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xu R, Jiang S, Zhou H and Jin W: Clinical
efficacy of ulinastatin combined with somatostatin for treatment of
severe acute pancreatitis and effects on immune function. Int J
Clin Exp Med. 12:11333–11341. 2019.
|
|
15
|
Li C, Ma D, Chen M, Zhang L, Zhang L,
Zhang J, Qu X and Wang C: Ulinastatin attenuates LPS-induced human
endothelial cells oxidative damage through suppressing JNK/c-Jun
signaling pathway. Biochem Biophys Res Commun. 474:572–578.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wei F, Liu SY, Luo L, Gu N, Zeng Y, Chen
X, Xu S and Zhang D: Anti-inflammatory mechanism of ulinastatin:
Inhibiting the hyperpermeability of vascular endothelial cells
induced by TNF-α via the RhoA/ROCK signal pathway. Int
Immunopharmacol. 46:220–227. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Schellerer VS, Langheinrich MC, Zver V,
Grützmann R, Stürzl M, Gefeller O, Naschberger E and Merkel S:
Soluble intercellular adhesion molecule-1 is a prognostic marker in
colorectal carcinoma. Int J Colorectal Dis. 34:309–317.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Staubli SM, Oertli D and Nebiker CA:
Laboratory markers predicting severity of acute pancreatitis. Crit
Rev Clin Lab Sci. 52:273–283. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bopp C, Hofer S, Weitz J, Bierhaus A,
Nawroth PP, Martin E, Büchler MW and Weigand MA: sRAGE is elevated
in septic patients and associated with patients outcome. J Surg
Res. 147:79–83. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhao B, Chen Y, Sun WW, Chen WW, Ma L,
Yang ZT, Huang J, Chen EZ, Fei J and Mao EQ: Effect of S100A12 and
soluble receptor for advanced glycation end products on the
occurrence of severe acute pancreatitis. J Dig Dis. 17:475–482.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Greenberg JA, Hsu J, Bawazeer M, Marshall
J, Friedrich JO, Nathens A, Coburn N, May GR, Pearsall E and McLeod
RS: Clinical practice guideline: Management of acute pancreatitis.
Can J Surg. 59:128–140. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Akavipat P, Thinkhamrop J, Thinkhamrop B
and Sriraj W: Acute physiology and chronic health evaluation
(APACHE) II score-the clinical predictor in neurosurgical intensive
care unit. Acta Clin Croat. 58:50–56. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hornbeck PV: Enzyme linked immunosorbent
assays. Curr Protoc Immunol. 110:2.1.1–2.1.23. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang ZW, Meng XX and Xu P: Central role of
neutrophil in the pathogenesis of severe acute pancreatitis. J Cell
Mol Med. 19:2513–2520. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Manohar M, Verma AK, Venkateshaiah SU,
Sanders NL and Mishra A: Pathogenic mechanisms of pancreatitis.
World J Gastrointest Pharmacol Ther. 8:10–25. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Saluja A and Maitra A: Pancreatitis and
pancreatic cancer. Gastroenterology. 156:1937–1940. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Shen X and Li WQ: High-mobility group box
1 protein and its role in severe acute pancreatitis. World J
Gastroenterol. 21:1424–1435. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang C, Wen J, Xia M and Wang SR: Effect
of glutamine nutrition support on the intestinal mucosal barrier
function and inflammatory response in patients with severe acute
pancreatitis. J Hainan Med Univ. 23:17–21. 2017.
|
|
29
|
Pan Y, Fang H, Lu F, Pan M, Chen F, Xiong
P, Yao Y and Huang H: Ulinastatin ameliorates tissue damage of
severe acute pancreatitis through modulating regulatory T cells. J
Inflamm (Lond). 14(7)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kuessel L, Wenzl R, Proestling K,
Balendran S, Pateisky P, Yotova I, Yerlikaya G, Streubel B and
Husslein H: Soluble VCAM-1/soluble ICAM-1 ratio is a promising
biomarker for diagnosing endometriosis. Hum Reprod. 32:770–779.
2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Budnik A, Grewe M, Gyufko K and Krutmann
J: Analysis of the production of soluble ICAM-1 molecules by human
cells. Exp Hematol. 24:352–359. 1996.PubMed/NCBI
|
|
32
|
Scavello F, Zeni F, Tedesco CC, Mensà E,
Veglia F, Procopio AD, Bonfigli AR, Olivieri F and Raucci A:
Modulation of soluble receptor for advanced glycation end-products
(RAGE) isoforms and their ligands in healthy aging. Aging (Albany
NY). 11:1648–1663. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Park JY, Jeon TJ, Ha TH, Hwang JT, Sinn
DH, Oh TH, Shin WC and Choi WC: Bedside index for severity in acute
pancreatitis: Comparison with other scoring systems in predicting
severity and organ failure. Hepatobiliary Pancreat Dis Int.
12:645–650. 2013.PubMed/NCBI View Article : Google Scholar
|
